{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:19:13Z","timestamp":1764181153856,"version":"3.46.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970703"],"award-info":[{"award-number":["31970703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012472","2025A1515010593"],"award-info":[{"award-number":["2022A1515012472","2025A1515010593"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,12,14]]},"DOI":"10.1038\/s41416-025-03203-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:46:20Z","timestamp":1758908780000},"page":"1733-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An ABCC1-based risk model is effective in the diagnosis of synchronous peritoneal metastasis in advanced colorectal cancer"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-8659","authenticated-orcid":false,"given":"Wenqing","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-8498","authenticated-orcid":false,"given":"Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8872-0592","authenticated-orcid":false,"given":"Daici","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"3203_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"3203_CR2","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians https:\/\/doi.org\/10.3322\/caac.21834 (2024).","DOI":"10.3322\/caac.21834"},{"key":"3203_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545\u201350.","journal-title":"Br J Surg"},{"key":"3203_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1245\/s10434-019-07970-z","volume":"27","author":"NB Arrizabalaga","year":"2020","unstructured":"Arrizabalaga NB, Navascu\u00e9s JME, Echaniz GE, Ansorena YS, Gal\u00e1n CP, Mart\u00edn XA, et al. Prophylactic HIPEC in pT4 colon tumors: proactive approach or overtreatment?. Ann Surg Oncol. 2020;27:1094\u20131100.","journal-title":"Ann Surg Oncol"},{"key":"3203_CR5","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol"},{"key":"3203_CR6","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370\u20137.","journal-title":"Ann Surg Oncol"},{"key":"3203_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol"},{"key":"3203_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae001","volume":"12","author":"T Lin","year":"2024","unstructured":"Lin T, Chen X, Xu Z, Hu Y, Liu H, Yu J, et al. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: a Phase II study of CLASS-05 trial. Gastroenterol Rep. 2024;12:goae001.","journal-title":"Gastroenterol Rep"},{"key":"3203_CR9","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","volume":"30","author":"I van \u2018t Sant","year":"2020","unstructured":"van \u2018t Sant I, Engbersen MP, Bhairosing PA, Lambregts DMJ, Beets-Tan RGH, van Driel WJ, et al. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radio. 2020;30:3101\u201312.","journal-title":"Eur Radio"},{"key":"3203_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00261-022-03464-x","volume":"47","author":"B Carlson","year":"2022","unstructured":"Carlson B, Harmath C, Turaga K, Kindler HL, Armato SG 3rd, Straus C. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review. Abdom Radio. 2022;47:1725\u201340.","journal-title":"Abdom Radio"},{"key":"3203_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16:327\u201333.","journal-title":"Ann Surg Oncol"},{"key":"3203_CR12","first-page":"Cd011134","volume":"2015","author":"BD Nicholson","year":"2015","unstructured":"Nicholson BD, Shinkins B, Pathiraja I, Roberts NW, James TJ, Mallett S, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015;2015:Cd011134.","journal-title":"Cochrane Database Syst Rev"},{"key":"3203_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/oxfordjournals.annonc.a059248","volume":"6","author":"A Webb","year":"1995","unstructured":"Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O\u2019Brien M, et al. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer. Ann Oncol. 1995;6:581\u20137.","journal-title":"Ann Oncol"},{"key":"3203_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.6004\/jnccn.2021.7101","volume":"20","author":"D Shen","year":"2022","unstructured":"Shen D, Wang X, Wang H, Xu G, Xie Y, Zhuang Z, et al. Current surveillance after treatment is not sufficient for patients with rectal cancer with negative baseline CEA. J Natl Compr Cancer Netw: JNCCN. 2022;20:653\u2013662.e653.","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"key":"3203_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2010.47","volume":"7","author":"S Kyriazi","year":"2010","unstructured":"Kyriazi S, Kaye SB, deSouza NM. Imaging ovarian cancer and peritoneal metastases-current and emerging techniques. Nat Rev Clin Oncol. 2010;7:381\u201393.","journal-title":"Nat Rev Clin Oncol"},{"key":"3203_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019;12:28.","journal-title":"J Ovarian Res"},{"key":"3203_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/s41416-022-01742-5","volume":"126","author":"J Laoukili","year":"2022","unstructured":"Laoukili J, Constantinides A, Wassenaar ECE, Elias SG, Raats DAE, van Schelven SJ, et al. Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. Br J Cancer. 2022;126:1824\u201333.","journal-title":"Br J Cancer"},{"key":"3203_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, Bhatt A, Ceelen W, Glehen O, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Prim. 2021;7:91.","journal-title":"Nat Rev Dis Prim"},{"key":"3203_CR19","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim et Biophys Acta Rev cancer. 2021;1875:188503.","journal-title":"Biochim et Biophys Acta Rev cancer"},{"key":"3203_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"},{"key":"3203_CR21","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"3203_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jclinpath-2019-206252","volume":"73","author":"J Yeong","year":"2020","unstructured":"Yeong J, Tan T, Chow ZL, Cheng Q, Lee B, Seet A, et al. Multiplex immunohistochemistry\/immunofluorescence (mIHC\/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC. J Clin Pathol. 2020;73:557\u201362.","journal-title":"J Clin Pathol"},{"key":"3203_CR23","doi-asserted-by":"crossref","unstructured":"Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020;369:eabb9601.","DOI":"10.1126\/science.abb9601"},{"key":"3203_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101171","volume":"14","author":"Q Wang","year":"2021","unstructured":"Wang Q, Liu W, Chen S, Luo Q, Li Y, Peng S, et al. ORMDL1 is upregulated and associated with favorable outcomes in colorectal cancer. Transl Oncol. 2021;14:101171.","journal-title":"Transl Oncol"},{"key":"3203_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s11658-023-00487-0","volume":"28","author":"W Liu","year":"2023","unstructured":"Liu W, Chen S, Xie W, Wang Q, Luo Q, Huang M, et al. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer. Cell Mol Biol Lett. 2023;28:80.","journal-title":"Cell Mol Biol Lett"},{"key":"3203_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tiv.2017.06.007","volume":"43","author":"L Celestino Pinto","year":"2017","unstructured":"Celestino Pinto L, de F\u00e1tima Aquino Moreira-Nunes C, Soares BM, Burbano RMR, de Lemos JAR, Montenegro RC. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis. Toxicol Vitr. 2017;43:87\u201391.","journal-title":"Toxicol Vitr"},{"key":"3203_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08996-6","volume":"23","author":"WK Shi","year":"2022","unstructured":"Shi WK, Liu YX, Qiu XY, Zhou JY, Zhou JL, Lin GL. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer. BMC Genom. 2022;23:764.","journal-title":"BMC Genom"},{"key":"3203_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13238-019-00674-w","volume":"11","author":"B Pan","year":"2020","unstructured":"Pan B, Yang Y, Li J, Wang Y, Fang C, Yu FX, et al. USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein cell. 2020;11:138\u201343.","journal-title":"Protein cell"},{"key":"3203_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1078-0432.CCR-16-0150","volume":"23","author":"KA Schalper","year":"2017","unstructured":"Schalper KA, Carvajal-Hausdorf D, McLaughlin J, Altan M, Velcheti V, Gaule P, et al. Differential expression and significance of PD-L1, IDO-1, and B7-H4 in human lung cancer. Clin Cancer Res. 2017;23:370\u20138.","journal-title":"Clin Cancer Res"},{"key":"3203_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/SLA.0000000000002116","volume":"267","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Zhang Q, Hu Y, Li T, Yu J, Zhao L, et al. ImmunoScore signature: a prognostic and predictive tool in gastric cancer. Ann Surg. 2018;267:504\u201313.","journal-title":"Ann Surg"},{"key":"3203_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s43657-022-00070-1","volume":"2","author":"A Anwaier","year":"2022","unstructured":"Anwaier A, Zhu S-X, Tian X, Xu W-H, Wang Y, Palihati M, et al. Large-scale proteomics data reveal integrated prognosis-related protein signatures and role of SMAD4 and RAD50 in prognosis and immune infiltrations of prostate cancer microenvironment. Phenomics. 2022;2:404\u201318.","journal-title":"Phenomics"},{"key":"3203_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","volume":"40","author":"D Akhoundova","year":"2022","unstructured":"Akhoundova D, Rubin MA. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future. Cancer cell. 2022;40:920\u201338.","journal-title":"Cancer cell"},{"key":"3203_CR33","doi-asserted-by":"crossref","unstructured":"Liu SL, Bian LJ, Liu ZX, Chen QY, Sun XS, Sun R, et al. Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma. J Immunother Cancer. 2020;8:e000205.","DOI":"10.1136\/jitc-2019-000205"},{"key":"3203_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fonc.2019.00439","volume":"9","author":"C Guo","year":"2019","unstructured":"Guo C, Zhao H, Wang Y, Bai S, Yang Z, Wei F, et al. Prognostic value of the neo-immunoscore in renal cell carcinoma. Front Oncol. 2019;9:439.","journal-title":"Front Oncol"},{"key":"3203_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18:452\u201364.","journal-title":"Nat Rev Cancer"},{"key":"3203_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","volume":"54","author":"SP Cole","year":"2014","unstructured":"Cole SP. Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. Annu Rev Pharm Toxicol. 2014;54:95\u2013117.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"3203_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28897-2","volume":"13","author":"J Zhou","year":"2023","unstructured":"Zhou J, Guo T, Zhou L, Bao M, Wang L, Zhou W, et al. The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma. Sci Rep. 2023;13:1861.","journal-title":"Sci Rep"},{"key":"3203_CR38","doi-asserted-by":"publisher","first-page":"e0261527","DOI":"10.1371\/journal.pone.0261527","volume":"17","author":"K Iwasaki","year":"2022","unstructured":"Iwasaki K, Cho H, Maezawa Y, Tsuchida K, Kano K, Fujikawa H, et al. Assessment of the use of computed tomography colonography in early detection of peritoneal metastasis in patients with gastric cancer: a prospective cohort study. PloS ONE. 2022;17:e0261527.","journal-title":"PloS ONE"},{"key":"3203_CR39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s10147-021-01918-8","volume":"26","author":"K Sato","year":"2021","unstructured":"Sato K, Imaizumi K, Kasajima H, Kurushima M, Umehara M, Tsuruga Y, et al. Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer. Int J Clin Oncol. 2021;26:1272\u201384.","journal-title":"Int J Clin Oncol"},{"key":"3203_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01479-9","volume":"15","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Chen W, Liu D, Qin Q, Grady WM, Fichera A, et al. Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study: A prospective diagnostic study. Clin Epigenet. 2023;15:65.","journal-title":"Clin Epigenet"},{"key":"3203_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00450-y","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H, Zheng Q, Lu Z, Wang L, Ding L, Xia L, et al. Role of the nervous system in cancers: a review. Cell Death Discov. 2021;7:76.","journal-title":"Cell Death Discov"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03203-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:15:30Z","timestamp":1764180930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03203-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,12,14]]}},"alternative-id":["3203"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03203-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"type":"print","value":"0007-0920"},{"type":"electronic","value":"1532-1827"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were conducted in accordance with the Declaration of Helsinki and approved by the Human Medical Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (approval number: 2022ZSLYEC-469). This study is a retrospective study and the information are anonymous. The authors had no access to any identifying information during the analysis of the data. In accordance with the relevant guidelines and regulations, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}